Published in Eur J Nucl Med Mol Imaging on January 11, 2008
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging (2013) 3.61
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging (2014) 3.40
Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline. J Nucl Med (2010) 1.98
Role of (18)F-choline PET/CT in evaluation of patients with prostate carcinoma. Radiol Oncol (2010) 1.68
Molecular Imaging of Prostate Cancer. Radiographics (2015) 1.51
Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer. Curr Med Chem (2012) 1.34
18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients. Eur J Nucl Med Mol Imaging (2013) 1.29
Molecular imaging of prostate cancer: PET radiotracers. AJR Am J Roentgenol (2012) 1.22
Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake. Am J Nucl Med Mol Imaging (2013) 1.21
Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer. Eur J Nucl Med Mol Imaging (2013) 1.21
GCPII imaging and cancer. Curr Med Chem (2012) 1.12
New acquisition protocol of 18F-choline PET/CT in prostate cancer patients: review of the literature about methodology and proposal of standardization. Biomed Res Int (2014) 1.09
Radiation dosimetry of (68)Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing. Eur J Nucl Med Mol Imaging (2016) 1.03
Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine. Am J Nucl Med Mol Imaging (2015) 0.99
Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer. Curr Opin Oncol (2009) 0.98
PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature. Eur J Nucl Med Mol Imaging (2010) 0.98
Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels. Eur J Nucl Med Mol Imaging (2008) 0.96
PET/CT Imaging and Radioimmunotherapy of Prostate Cancer. Semin Nucl Med (2011) 0.95
2-18F-Fluoropropionic acid as a PET imaging agent for prostate cancer. J Nucl Med (2009) 0.90
Active inflammation in 18F-methylcholine PET/CT. Eur J Nucl Med Mol Imaging (2009) 0.88
Initial prostate cancer diagnosis and disease staging--the role of choline-PET-CT. Nat Rev Urol (2015) 0.84
Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm. Cancer Treat Rev (2012) 0.83
Choline autoradiography of human prostate cancer xenograft: effect of castration. Mol Imaging (2009) 0.83
Dual-phase PET-CT to differentiate [18F]Fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancer. PLoS One (2012) 0.82
Modalities for imaging of prostate cancer. Adv Urol (2010) 0.80
Occult Prostate Cancer Detected with 18F-Fluorocholine Positron Emission Tomography/Computed Tomography. World J Nucl Med (2014) 0.79
(68)Ga-PSMA-11 dynamic PET/CT imaging in biochemical relapse of prostate cancer. Eur J Nucl Med Mol Imaging (2016) 0.78
Study of inter- and intra-observer reproducibility in the interpretation of [(18)F]choline PET/CT examinations in patients suffering from biochemically recurrent prostate cancer following curative treatment. EJNMMI Res (2014) 0.78
The Utility of Molecular Imaging in Prostate Cancer. Curr Urol Rep (2016) 0.78
Giant Schmorl's Node may Cause High Uptake and Mimic a Bone Metastasis on (18)F-Choline Positron Emission Tomography/Computed Tomography. World J Nucl Med (2015) 0.75
68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients. Oncotarget (2017) 0.75
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med (2004) 15.10
Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med (1991) 6.94
Prostate cancer epidemiology. Lancet (2003) 6.30
Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res (1999) 3.23
Studies of human tumors by MRS: a review. NMR Biomed (1993) 2.44
Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. Radiology (1999) 2.32
Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol (1994) 2.25
Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun (2002) 2.09
Screening for prostatic carcinoma with prostate specific antigen. J Urol (1992) 2.03
PET imaging of prostate cancer using carbon-11-choline. J Nucl Med (1998) 1.92
Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol (1998) 1.88
Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study. J Urol (1999) 1.75
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology (1996) 1.72
Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res (2001) 1.67
Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol (2002) 1.48
Increased choline kinase activity and elevated phosphocholine levels in human colon cancer. Jpn J Cancer Res (1999) 1.38
Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. J Nucl Med (2006) 1.38
Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer. Eur J Nucl Med Mol Imaging (2006) 1.35
Prostate cancer detection at low prostate specific antigen. J Urol (2000) 1.34
Kinetics of [(11)C]choline uptake in prostate cancer: a PET study. Eur J Nucl Med Mol Imaging (2003) 1.27
Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology (2005) 1.25
Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol (1997) 1.14
Pharmacokinetics and radiation dosimetry of 18F-fluorocholine. J Nucl Med (2002) 1.09
Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations. Radiology (2004) 1.09
Repeat prostate needle biopsy: who needs it? J Urol (1995) 1.06
18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET. Eur J Nucl Med Mol Imaging (2003) 1.05
Positron emission tomography in urological oncology. J Urol (1998) 1.02
11C-choline and 2-deoxy-2-[18F]fluoro-D-glucose in tumor imaging with positron emission tomography. Mol Imaging Biol (2002) 0.91
Using gray-scale and two different techniques of color Doppler sonography to detect prostate cancer. Urology (2003) 0.91
Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies. Int J Cancer (1993) 0.87
Diagnosis of prostate cancer. State of the art. Minerva Urol Nefrol (2004) 0.75
Prostate cancer pathology, screening, and epidemiology. Rev Urol (2001) 0.75
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature (1986) 4.81
Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging (2008) 2.67
Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation (2002) 2.44
Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke (2002) 2.11
Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation (2002) 2.09
The cell attachment domain of fibronectin. Determination of the primary structure. J Biol Chem (1982) 2.03
The complete nucleotide sequence of the I-E alpha d immune response gene. Nucleic Acids Res (1983) 1.75
Conditional dependence between tests affects the diagnosis and surveillance of animal diseases. Prev Vet Med (2000) 1.54
Technetium-99m-MIBI scintigraphy of thyroid nodules in an endemic goiter area. J Nucl Med (1997) 1.47
Attenuation correction improves the detection of viable myocardium by thallium-201 cardiac tomography in patients with previous myocardial infarction and left ventricular dysfunction. Eur J Nucl Med (1999) 1.46
Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy. Proc Natl Acad Sci U S A (1994) 1.38
Thyroid hemiagenesis in an endemic goiter area diagnosed by ultrasonography: report of sixteen patients. Thyroid (1999) 1.33
Sensitivity and specificity of various serologic tests for detection of Toxoplasma gondii infection in naturally infected sows. Am J Vet Res (1995) 1.32
Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs. J Med Chem (1995) 1.30
Complex formation of class I transplantation antigens and a viral glycoprotein. J Biol Chem (1983) 1.24
Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. J Immunol (1997) 1.22
The serological response to Salmonella serovars typhimurium and infantis in experimentally infected pigs. The time course followed with an indirect anti-LPS ELISA and bacteriological examinations. Vet Microbiol (1995) 1.21
Clinical outcome of radiosynoviorthesis: a meta-analysis including 2190 treated joints. Nucl Med Commun (2002) 1.19
The primary structure of rabbit and rat prealbumin and a comparison with the tertiary structure of human prealbumin. J Biol Chem (1985) 1.18
Expression of functional leptin receptors in the human ovary. J Clin Endocrinol Metab (1997) 1.18
High mite-allergen exposure increases the risk of sensitization in atopic children and young adults. J Allergy Clin Immunol (1989) 1.11
Antigenic analysis of household dust samples. Am Rev Respir Dis (1988) 1.11
p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma. Blood (1998) 1.08
Serodiagnosis of Salmonella dublin infection in Danish dairy herds using O-antigen based enzyme-linked immunosorbent assay. Can J Vet Res (1994) 1.06
Interpretation of the gamma interferon test for diagnosis of subclinical paratuberculosis in cattle. Clin Diagn Lab Immunol (2002) 1.05
Workers exposed to thermal degradation products of TDI- and MDI-based polyurethane: biomonitoring of 2,4-TDA, 2,6-TDA, and 4,4'-MDA in hydrolyzed urine and plasma. Am Ind Hyg Assoc J (1997) 1.03
Evaluation of an O antigen enzyme-linked immunosorbent assay for screening of milk samples for Salmonella dublin infection in dairy herds. Can J Vet Res (1995) 1.03
Neospora caninum infection and repeated abortions in humans. Emerg Infect Dis (1999) 1.03
Relating radiation-induced regional lung injury to changes in pulmonary function tests. Int J Radiat Oncol Biol Phys (2001) 1.01
Epidemiology of thyroid diseases in iodine sufficiency. Thyroid (1998) 1.01
Molecular characterization of Danish Cryptosporidium parvum isolates. Parasitology (2002) 1.01
Embryonation and infectivity of Ascaris suum eggs. A comparison of eggs collected from worm uteri with eggs isolated from pig faeces. Acta Vet Scand (1990) 1.00
Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys (2000) 0.99
Immunotherapy of human colon cancer by antibody-targeted superantigens. Cancer Immunol Immunother (1995) 0.99
Cryptosporidium andersoni from a Danish cattle herd: identification and preliminary characterisation. Vet Parasitol (2002) 0.98
Posttherapeutic (131)I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen. Eur J Nucl Med Mol Imaging (2009) 0.98
Standardization of Dermatophagoides pteronyssinus: assessment of potency and allergen content in ten coded extracts. Int Arch Allergy Appl Immunol (1985) 0.98
complete amino-acid sequence of a non-neurotoxic, non-enzymatic phospholipase A2 homolog from the venom of the Australian tiger snake Notechis scutatus scutatus. Eur J Biochem (1980) 0.98
The primary structure of rat liver cellular retinol-binding protein. J Biol Chem (1985) 0.97
99mTc-DTPA aerosol for same-day post-perfusion ventilation imaging: results of a multicentre study. Eur J Nucl Med (1993) 0.97
Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma. J Nucl Med (1997) 0.97
The incidence of hyperthyroidism in Austria from 1987 to 1995 before and after an increase in salt iodization in 1990. Eur J Nucl Med (1998) 0.96
Molecular cloning and RNA expression of two new human chemokine receptor-like genes. Biochem Biophys Res Commun (1996) 0.96
Use of muscle fluid as a source of antibodies for serologic detection of Salmonella infection in slaughter pig herds. J Vet Diagn Invest (1998) 0.96
Attenuation-corrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalities. Eur J Nucl Med (1998) 0.95
Schwannoma of the neck simulating a thyroid nodule. Thyroid (1997) 0.94
Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med (2001) 0.93
Study of the infectivity of saline-stored Campylobacter jejuni for day-old chicks. Appl Environ Microbiol (2001) 0.93
Monoclonal antibodies to the major feline allergen Fel d I. I. Serologic and biologic activity of affinity-purified Fel d I and of Fel d I-depleted extract. J Allergy Clin Immunol (1988) 0.92
Associations of Neospora caninum seropositivity with gestation number and pregnancy outcome in Danish dairy herds. Prev Vet Med (1999) 0.92
Comparison between persisting anti-lipopolysaccharide antibodies and culture at postmortem in salmonella-infected cattle herds. Vet Microbiol (1996) 0.91
Determination of toluenediamine isomers by capillary gas chromatography and chemical ionization mass spectrometry with special reference to the biological monitoring of 2,4- and 2,6-toluene diisocyanate. J Chromatogr A (1994) 0.91
Molecular characterization of the complement activating protein in the venom of the Indian cobra (Naja N. siamensis). Mol Immunol (1981) 0.91
Experimental porcine neosporosis. APMIS (1998) 0.90
Development of murine monoclonal antibodies for the immunohistochemical diagnosis of systemic bovine aspergillosis. J Vet Diagn Invest (1996) 0.89
Testing of bulk tank milk for Salmonella Dublin infection in Danish dairy herds. Can J Vet Res (2001) 0.89
Trichinella spiralis, T. britovi, and T. nativa: infectivity, larval distribution in muscle, and antibody response after experimental infection of pigs. Parasitol Res (1998) 0.89
Specific immunoglobulin measurements related to exposure and resistance to Schistosoma mansoni infection in Sudanese canal cleaners. Clin Exp Immunol (1996) 0.89
Short-term study of the uptake of PrP(Sc) by the Peyer's patches in hamsters after oral exposure to scrapie. J Comp Pathol (2006) 0.88
In utero infection with porcine reproductive and respiratory syndrome virus modulates leukocyte subpopulations in peripheral blood and bronchoalveolar fluid of surviving piglets. Vet Immunol Immunopathol (2003) 0.88
Identification of allergens in Dermatophagoides pteronyssinus mite body extract by crossed radioimmunoelectrophoresis with two different rabbit antibody pools. Scand J Immunol (1983) 0.88
Isolation, partial characterization, and molecular cloning of a human colon adenocarcinoma cell-surface glycoprotein recognized by the C215 mouse monoclonal antibody. J Biol Chem (1993) 0.88
Experimental Ascaris suum infection in the pig: protective memory response after three immunizations and effect of intestinal adult worm population. Parasite Immunol (1999) 0.87
Non-lethal infection parameters in mice separate sheep Type II Toxoplasma gondii isolates by virulence. Comp Immunol Microbiol Infect Dis (2002) 0.87
Characterisation of Toxoplasma gondii isolates using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) of the non-coding Toxoplasma gondii (TGR)-gene sequences. Int J Parasitol (2000) 0.87
Longitudinal study of interferon-gamma, serum antibody and milk antibody responses in cattle infected with Mycobacterium avium subsp. paratuberculosis. Vet Microbiol (2004) 0.86
Response to repeated inoculations with Ascaris suum eggs in pigs during the fattening period. I. Studies on worm population kinetics. Parasitol Res (1992) 0.86
Clinical observations, pathology, bioassay in mice and serological response at slaughter in pigs experimentally infected with Toxoplasma gondii. Vet Parasitol (1997) 0.85
Taipoxin, an extremely potent presynaptic snake venom neurotoxin. Elucidation of the primary structure of the acidic carbohydrate-containing taipoxin-subunit, a prophospholipase homolog. FEBS Lett (1977) 0.85
Amino-acid sequence of the alpha-subunit of taipoxin, an extremely potent presynaptic neurotoxin from the Australian snake taipan (Oxyuranus s. scutellatus). Eur J Biochem (1982) 0.85
Pathogenicity of selected Toxoplasma gondii isolates in young pigs. Int J Parasitol (1999) 0.85
Population dynamics of Toxocara canis in pigs receiving a single or multiple infection. Parasitology (2003) 0.85
F-18 fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory bowel disease. Clin Nucl Med (2001) 0.84
Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphoma. Acta Med Austriaca (2003) 0.84
Unusual malabsorption of levothyroxine. Thyroid (2000) 0.84
Non-Q-wave myocardial infarction associated with bleomycin and etoposide chemotherapy. Eur Heart J (1991) 0.84
Iodine supplementation in Austria: methods and results. Thyroid (2002) 0.84